Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306409796> ?p ?o ?g. }
- W4306409796 abstract "Clinicians in the emergency department (ED) face challenges in concurrently assessing patients with suspected COVID-19 infection, detecting bacterial coinfection, and determining illness severity since current practices require separate workflows. Here, we explore the accuracy of the IMX-BVN-3/IMX-SEV-3 29 mRNA host response classifiers in simultaneously detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and bacterial coinfections and predicting clinical severity of COVID-19. A total of 161 patients with PCR-confirmed COVID-19 (52.2% female; median age, 50.0 years; 51% hospitalized; 5.6% deaths) were enrolled at the Stanford Hospital ED. RNA was extracted (2.5 mL whole blood in PAXgene blood RNA), and 29 host mRNAs in response to the infection were quantified using Nanostring nCounter. The IMX-BVN-3 classifier identified SARS-CoV-2 infection in 151 patients with a sensitivity of 93.8%. Six of 10 patients undetected by the classifier had positive COVID tests more than 9 days prior to enrollment, and the remaining patients oscillated between positive and negative results in subsequent tests. The classifier also predicted that 6 (3.7%) patients had a bacterial coinfection. Clinical adjudication confirmed that 5/6 (83.3%) of the patients had bacterial infections, i.e., Clostridioides difficile colitis (n = 1), urinary tract infection (n = 1), and clinically diagnosed bacterial infections (n = 3), for a specificity of 99.4%. Two of 101 (2.8%) patients in the IMX-SEV-3 Low severity classification and 7/60 (11.7%) in the Moderate severity classification died within 30 days of enrollment. IMX-BVN-3/IMX-SEV-3 classifiers accurately identified patients with COVID-19 and bacterial coinfections and predicted patients' risk of death. A point-of-care version of these classifiers, under development, could improve ED patient management, including more accurate treatment decisions and optimized resource utilization. IMPORTANCE We assay the utility of the single-test IMX-BVN-3/IMX-SEV-3 classifiers that require just 2.5 mL of patient blood in concurrently detecting viral and bacterial infections as well as predicting the severity and 30-day outcome from the infection. A point-of-care device, in development, will circumvent the need for blood culturing and drastically reduce the time needed to detect an infection. This will negate the need for empirical use of broad-spectrum antibiotics and allow for antibiotic use stewardship. Additionally, accurate classification of the severity of infection and the prediction of 30-day severe outcomes will allow for appropriate allocation of hospital resources." @default.
- W4306409796 created "2022-10-17" @default.
- W4306409796 creator A5000203760 @default.
- W4306409796 creator A5004456222 @default.
- W4306409796 creator A5006749713 @default.
- W4306409796 creator A5008729380 @default.
- W4306409796 creator A5011918051 @default.
- W4306409796 creator A5014323653 @default.
- W4306409796 creator A5015656765 @default.
- W4306409796 creator A5017140133 @default.
- W4306409796 creator A5020491178 @default.
- W4306409796 creator A5021382133 @default.
- W4306409796 creator A5022016147 @default.
- W4306409796 creator A5024617071 @default.
- W4306409796 creator A5026456130 @default.
- W4306409796 creator A5027307064 @default.
- W4306409796 creator A5027655714 @default.
- W4306409796 creator A5028760615 @default.
- W4306409796 creator A5029316595 @default.
- W4306409796 creator A5029958672 @default.
- W4306409796 creator A5030336166 @default.
- W4306409796 creator A5031492297 @default.
- W4306409796 creator A5034015016 @default.
- W4306409796 creator A5034194448 @default.
- W4306409796 creator A5034944160 @default.
- W4306409796 creator A5038872432 @default.
- W4306409796 creator A5039621270 @default.
- W4306409796 creator A5041327310 @default.
- W4306409796 creator A5043901319 @default.
- W4306409796 creator A5044643663 @default.
- W4306409796 creator A5046085825 @default.
- W4306409796 creator A5046815252 @default.
- W4306409796 creator A5049082600 @default.
- W4306409796 creator A5049127292 @default.
- W4306409796 creator A5051195358 @default.
- W4306409796 creator A5053360118 @default.
- W4306409796 creator A5054876585 @default.
- W4306409796 creator A5057679568 @default.
- W4306409796 creator A5057717220 @default.
- W4306409796 creator A5062431104 @default.
- W4306409796 creator A5064975456 @default.
- W4306409796 creator A5065175821 @default.
- W4306409796 creator A5066092294 @default.
- W4306409796 creator A5066738610 @default.
- W4306409796 creator A5067871955 @default.
- W4306409796 creator A5068243893 @default.
- W4306409796 creator A5068822395 @default.
- W4306409796 creator A5070002999 @default.
- W4306409796 creator A5072742167 @default.
- W4306409796 creator A5075216970 @default.
- W4306409796 creator A5075711252 @default.
- W4306409796 creator A5078223903 @default.
- W4306409796 creator A5080722924 @default.
- W4306409796 creator A5083604044 @default.
- W4306409796 creator A5085442010 @default.
- W4306409796 creator A5086746858 @default.
- W4306409796 creator A5086888258 @default.
- W4306409796 creator A5088144945 @default.
- W4306409796 creator A5088207875 @default.
- W4306409796 creator A5090888026 @default.
- W4306409796 date "2022-12-21" @default.
- W4306409796 modified "2023-10-17" @default.
- W4306409796 title "Using a 29-mRNA Host Response Classifier To Detect Bacterial Coinfections and Predict Outcomes in COVID-19 Patients Presenting to the Emergency Department" @default.
- W4306409796 cites W1984968738 @default.
- W4306409796 cites W1995615618 @default.
- W4306409796 cites W2138096026 @default.
- W4306409796 cites W2341045092 @default.
- W4306409796 cites W2474277182 @default.
- W4306409796 cites W2789690286 @default.
- W4306409796 cites W2904662596 @default.
- W4306409796 cites W2946491575 @default.
- W4306409796 cites W3006926536 @default.
- W4306409796 cites W3010267838 @default.
- W4306409796 cites W3023402775 @default.
- W4306409796 cites W3037794822 @default.
- W4306409796 cites W3041831980 @default.
- W4306409796 cites W3043975336 @default.
- W4306409796 cites W3044123186 @default.
- W4306409796 cites W3081593936 @default.
- W4306409796 cites W3088952172 @default.
- W4306409796 cites W3094047950 @default.
- W4306409796 cites W3111415204 @default.
- W4306409796 cites W3156713432 @default.
- W4306409796 cites W3156751337 @default.
- W4306409796 cites W3157790706 @default.
- W4306409796 cites W3165545115 @default.
- W4306409796 cites W3173831315 @default.
- W4306409796 cites W3185215874 @default.
- W4306409796 cites W3185453370 @default.
- W4306409796 cites W3209622805 @default.
- W4306409796 cites W4224447366 @default.
- W4306409796 doi "https://doi.org/10.1128/spectrum.02305-22" @default.
- W4306409796 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36250865" @default.
- W4306409796 hasPublicationYear "2022" @default.
- W4306409796 type Work @default.
- W4306409796 citedByCount "0" @default.
- W4306409796 crossrefType "journal-article" @default.
- W4306409796 hasAuthorship W4306409796A5000203760 @default.
- W4306409796 hasAuthorship W4306409796A5004456222 @default.
- W4306409796 hasAuthorship W4306409796A5006749713 @default.